关注
Cheryl Fitzer-Attas
Cheryl Fitzer-Attas
ClinMed LLC
在 clinmedaffairs.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages
MT Crowley, PS Costello, CJ Fitzer-Attas, M Turner, F Meng, C Lowell, ...
Journal of Experimental Medicine 186 (7), 1027-1039, 1997
6591997
Fcγ receptor–mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn
CJ Fitzer-Attas, M Lowry, MT Crowley, AJ Finn, F Meng, AL DeFranco, ...
Journal of Experimental Medicine 191 (4), 669-682, 2000
3282000
Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
JC Goldsack, A Coravos, JP Bakker, B Bent, AV Dowling, C Fitzer-Attas, ...
npj digital Medicine 3 (1), 55, 2020
3172020
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in …
O Rascol, CJ Fitzer-Attas, R Hauser, J Jankovic, A Lang, JW Langston, ...
The Lancet Neurology 10 (5), 415-423, 2011
2692011
An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-β derivatives
EM Sigurdsson, E Knudsen, A Asuni, C Fitzer-Attas, D Sage, ...
Journal of Neuroscience 24 (28), 6277-6282, 2004
1902004
Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
RA Hauser, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, CJ Fitzer‐Attas, ...
Movement Disorders 24 (4), 564-573, 2009
1852009
Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas
JG Guillem, CA O'Brian, CJ Fitzer, KA Forde, P LoGerfo, M Treat, ...
Cancer research 47 (8), 2036-2039, 1987
1751987
Data Analytics from Enroll‐HD, a Global Clinical Research Platform for Huntington's Disease
GB Landwehrmeyer, CJ Fitzer‐Attas, JD Giuliano, N Gonçalves, ...
Movement Disorders Clinical Practice 4 (2), 212-224, 2017
1722017
Increased melanoma risk in Parkinson disease: a prospective clinicopathological study
JM Bertoni, JP Arlette, HH Fernandez, C Fitzer-Attas, K Frei, MN Hassan, ...
Archives of neurology 67 (3), 347-352, 2010
1342010
Increased melanoma risk in Parkinson disease: a prospective clinicopathological study
JM Bertoni, JP Arlette, HH Fernandez, C Fitzer-Attas, K Frei, MN Hassan, ...
Archives of neurology 67 (3), 347-352, 2010
1342010
The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids
CJ Fitzer, CA O'Brian, JG Guillem, IB Weinstein
Carcinogenesis 8 (2), 217-220, 1987
1311987
Mechanisms compensating for dopamine loss in early Parkinson disease
J Brotchie, C Fitzer-Attas
Neurology 72 (7 Supplement 2), S32-S38, 2009
1212009
HD‐CAB: A cognitive assessment battery for clinical trials in Huntington's disease1,2,3
JC Stout, S Queller, KN Baker, S Cowlishaw, C Sampaio, C Fitzer‐Attas, ...
Movement Disorders 29 (10), 1281-1288, 2014
1072014
The T-body approach: potential for cancer immunotherapy
Z Eshhar, N Bach, CJ Fitzer-Attas, G Grosse, J Lustgarten, T Waks, ...
Springer seminars in immunopathology 18, 199-209, 1996
1061996
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
W Poewe, K Seppi, CJ Fitzer-Attas, GK Wenning, S Gilman, PA Low, ...
The Lancet Neurology 14 (2), 145-152, 2015
962015
Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation
CJ Fitzer-Attas, DG Schindler, T Waks, Z Eshhar
The Journal of Immunology 160 (1), 145-154, 1998
871998
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study
M Masellis, S Collinson, N Freeman, M Tampakeras, J Levy, A Tchelet, ...
Brain 139 (7), 2050-2062, 2016
712016
Studies on protein kinase C and colon carcinogenesis
JG Guillem, CA O'Brian, CJ Fitzer, MD Johnson, KA Forde, P LoGerfo, ...
Archives of Surgery 122 (12), 1475-1478, 1987
561987
Long‐term effects of rasagiline and the natural history of treated Parkinson's disease
O Rascol, RA Hauser, F Stocchi, CJ Fitzer‐Attas, Y Sidi, V Abler, ...
Movement Disorders 31 (10), 1489-1496, 2016
542016
Direct T cell activation by chimeric single chain Fv-Syk promotes Syk-Cbl association and Cbl phosphorylation
CJ Fitzer-Attas, DG Schindler, T Waks, Z Eshhar
Journal of Biological Chemistry 272 (13), 8551-8557, 1997
441997
系统目前无法执行此操作,请稍后再试。
文章 1–20